<?xml version="1.0" encoding="UTF-8"?>

<Bundle xmlns="http://hl7.org/fhir">
  <id value="TransurethralEnucleationDocument"/>
  <type value="document"/>
  <timestamp value="2024-04-15T08:00:00+01:00"/>
  <entry>
    <fullUrl value="http://prostatecancerspec.org/Composition/TransurethralEnucleationComposition"/>
    <resource>
      <Composition>
        <id value="TransurethralEnucleationComposition"/>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="Composition_TransurethralEnucleationComposition"> </a><p class="res-header-id"><b>Generated Narrative: Composition TransurethralEnucleationComposition</b></p><a name="TransurethralEnucleationComposition"> </a><a name="hcTransurethralEnucleationComposition"> </a><p><b>identifier</b>: Accession ID/PATH-COMP-2024-004</p><p><b>status</b>: Final</p><p><b>type</b>: <span title="Codes:{http://ihe-d.de/CodeSystems/IHEXDStypeCode PATH}, {http://snomed.info/sct 721967005}">Tissue pathology biopsy report</span></p><p><b>encounter</b>: <a href="Encounter-TransurethralEnucleationEncounter.html">Encounter: identifier = http://example.hospital.de/encounters#E_24_004; status = finished; class = IMP (IMP)</a></p><p><b>date</b>: 2024-04-15 08:00:00+0100</p><p><b>author</b>: <a href="Organization-PathologyLabOrganization.html">Pathologisches Institut</a></p><p><b>title</b>: Histopathologischer Befundbericht - Prostata Enucleation</p><h3>Attesters</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Mode</b></td><td><b>Party</b></td></tr><tr><td style="display: none">*</td><td>Legal</td><td><a href="Organization-PathologyLabOrganization.html">Organization Pathologielabor</a></td></tr></table><p><b>custodian</b>: <a href="Organization-PathologyLabOrganization.html">Organization Pathologielabor</a></p><h3>Events</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td><td><b>Detail</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://terminology.hl7.org/CodeSystem/v3-ActCode PATREPE}">pathology report entry task</span></td><td><a href="ServiceRequest-TransurethralEnucleationReportRequest.html">ServiceRequest Simple prostatectomy (procedure)</a></td></tr></table></div>
        </text>
        <identifier>
          <type>
            <coding>
              <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
              <code value="ACSN"/>
              <display value="Accession ID"/>
            </coding>
          </type>
          <system value="http://example.hospital.de/pathology-reports"/>
          <value value="PATH-COMP-2024-004"/>
        </identifier>
        <status value="final"/>
        <type>
          <coding>
            <system value="http://ihe-d.de/CodeSystems/IHEXDStypeCode"/>
            <code value="PATH"/>
          </coding>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="721967005"/>
            <display value="Tissue pathology biopsy report"/>
          </coding>
        </type>
        <subject>
          <reference value="Patient/Patient3"/>
          <display value="Klaus Becker, geb. 10.11.1958 (PAT-2024-003)"/>
        </subject>
        <encounter>
          <reference value="Encounter/TransurethralEnucleationEncounter"/>
        </encounter>
        <date value="2024-04-15T08:00:00+01:00"/>
        <author>
          <reference value="Organization/PathologyLabOrganization"/>
          <display value="Pathologisches Institut"/>
        </author>
        <title value="Histopathologischer Befundbericht - Prostata Enucleation"/>
        <attester>
          <mode value="legal"/>
          <party>
            <reference value="Organization/PathologyLabOrganization"/>
          </party>
        </attester>
        <custodian>
          <reference value="Organization/PathologyLabOrganization"/>
        </custodian>
        <event>
          <code>
            <coding>
              <system value="http://terminology.hl7.org/CodeSystem/v3-ActCode"/>
              <code value="PATREPE"/>
            </coding>
          </code>
          <detail>
            <reference value="ServiceRequest/TransurethralEnucleationReportRequest"/>
          </detail>
        </event>
        <section>
          <title value="Pathologiebefundbericht"/>
          <code>
            <coding>
              <system value="http://loinc.org"/>
              <code value="11526-1"/>
              <display value="Pathology study"/>
            </coding>
          </code>
          <text>
            <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><h3>Klinische Angaben</h3><p>Obstruktive Miktionsbeschwerden. PSA 12,5 ng/ml. Prostata-Enukleation (HoLEP/ThuLEP). V.a. Prostatakarzinom.</p><h3>Makroskopie</h3><table border="1" cellpadding="4" cellspacing="0"><tbody><tr><td>Präparat</td><td>Prostata-Enukleationspräparat</td></tr><tr><td>Gewicht</td><td>25 g</td></tr><tr><td>Maße (L × B × T)</td><td>3,5 × 2,8 × 2,2 cm</td></tr><tr><td>Samenblasen</td><td>Nicht im Resektat</td></tr><tr><td>Lymphknoten</td><td>Nicht im Resektat</td></tr></tbody></table><h3>Mikroskopie</h3><p>Azinäres Adenokarzinom der Prostata mit invasiven cribriformen Anteilen und intraduktalem Karzinom. Extensive Tumorinfiltration mit perineuralem und lymphovaskulärem Befall.</p><h3>Diagnostische Schlussfolgerung</h3><p><b>Diagnose:</b> Azinäres Adenokarzinom der Prostata (ICD-O 8140/3) – High-grade</p><table border="1" cellpadding="4" cellspacing="0"><tbody><tr><td>Histologischer Typ</td><td>Azinäres Adenokarzinom mit invasiven kribriformen Anteilen (8140/3)</td></tr><tr><td>Gleason-Score</td><td>4+5=9</td></tr><tr><td>ISUP-Gradgruppe</td><td>5 (WHO 2016)</td></tr><tr><td>Tumoranteil</td><td>60%</td></tr><tr><td>Anteil Gleason 4/5</td><td>90%</td></tr><tr><td>Intraduktales Karzinom</td><td>Nachgewiesen</td></tr><tr><td>Invasives kribriformes Karzinom</td><td>Nachgewiesen</td></tr><tr><td>Extraprostatische Ausbreitung</td><td>Nachgewiesen</td></tr><tr><td>Samenblaseninfiltration</td><td>Nachgewiesen</td></tr><tr><td>Lymphovaskuläre Invasion</td><td>Nachgewiesen</td></tr><tr><td>Perineurale Infiltration</td><td>Nachgewiesen</td></tr></tbody></table><p><b>Empfehlung:</b> Staging-Untersuchungen und interdisziplinäre Tumorkonferenz.</p></div>
          </text>
          <entry>
            <reference value="DiagnosticReport/TransurethralEnucleationReport"/>
          </entry>
        </section>
      </Composition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://prostatecancerspec.org/Patient/Patient3"/>
    <resource>
      <Patient>
        <id value="Patient3"/>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="Patient_Patient3"> </a><p class="res-header-id"><b>Generated Narrative: Patient Patient3</b></p><a name="Patient3"> </a><a name="hcPatient3"> </a><p style="border: 1px #661aff solid; background-color: #e6e6ff; padding: 10px;">Klaus Becker  Male, DoB: 1958-11-10 ( http://example.hospital.de/patient-ids#PAT-2024-003)</p><hr/></div>
        </text>
        <identifier>
          <system value="http://example.hospital.de/patient-ids"/>
          <value value="PAT-2024-003"/>
        </identifier>
        <name>
          <family value="Becker"/>
          <given value="Klaus"/>
        </name>
        <gender value="male"/>
        <birthDate value="1958-11-10"/>
      </Patient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://prostatecancerspec.org/Organization/PathologyLabOrganization"/>
    <resource>
      <Organization>
        <id value="PathologyLabOrganization"/>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="Organization_PathologyLabOrganization"> </a><p class="res-header-id"><b>Generated Narrative: Organization PathologyLabOrganization</b></p><a name="PathologyLabOrganization"> </a><a name="hcPathologyLabOrganization"> </a><p><b>identifier</b>: <code>http://example.hospital.de/organization-ids</code>/ORG-PATH-001</p><p><b>name</b>: Pathologielabor</p></div>
        </text>
        <identifier>
          <system value="http://example.hospital.de/organization-ids"/>
          <value value="ORG-PATH-001"/>
        </identifier>
        <name value="Pathologielabor"/>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://prostatecancerspec.org/DiagnosticReport/TransurethralEnucleationReport"/>
    <resource>
      <DiagnosticReport>
        <id value="TransurethralEnucleationReport"/>
        <meta>
          <profile value="https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-report|2026.0.0"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="DiagnosticReport_TransurethralEnucleationReport"> </a><p class="res-header-id"><b>Generated Narrative: DiagnosticReport TransurethralEnucleationReport</b></p><a name="TransurethralEnucleationReport"> </a><a name="hcTransurethralEnucleationReport"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="https://simplifier.net/resolve?scope=de.medizininformatikinitiative.kerndatensatz.patho@2026.0.0&amp;canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-report">MII PR Patho Reportversion: null2026.0.0)</a></p></div><h2><span title="Codes:{http://loinc.org 60568-3}">Pathology Synoptic report</span> (<span title="Codes:{http://terminology.hl7.org/CodeSystem/v2-0074 SP}">Surgical Pathology</span>) </h2><table class="grid"><tr><td>Subject</td><td>Klaus Becker  Male, DoB: 1958-11-10 ( http://example.hospital.de/patient-ids#PAT-2024-003)</td></tr><tr><td>When For</td><td>2024-05-12 17:00:00+0100</td></tr><tr><td>Reported</td><td>2024-05-13 08:00:00+0100</td></tr><tr><td>Performer</td><td> <a href="Practitioner-PathologistPractitioner.html">Practitioner Maria Schneider </a></td></tr><tr><td>Identifier</td><td> Accession ID/E_24_004</td></tr></table><p><b>Report Details</b></p><table class="grid"><tr><td><b>Code</b></td><td><b>Value</b></td><td><b>Flags</b></td><td><b>Note</b></td><td><b>When For</b></td></tr><tr><td><a href="Observation-TransurethralEnucleationMacroscopicGrouper.html"><span title="Codes:{http://loinc.org 22634-0}">Pathology report gross observation Narrative</span></a> (<span title="Codes:{http://snomed.info/sct 41216001}">Prostatic structure (body structure)</span>)</td><td>Makroskopische Messungen des Prostata Enucleation Präparats</td><td>Final</td><td><blockquote><div><p>Makroskopische Aufarbeitung des Prostata Enucleation Präparats: Gewicht 25g, Länge 3.5cm, Breite 2.8cm, Tiefe 2.2cm. Keine Samenblasen im Resektat. Keine Lymphknoten im Resektat.</p>
</div></blockquote></td><td>2024-04-11 14:00:00+0100</td></tr><tr><td><a href="Observation-TransurethralEnucleationDiagnosticConclusionGrouper.html"><span title="Codes:{http://loinc.org 22637-3}">Pathology report final diagnosis Narrative</span></a></td><td/><td>Final</td><td><blockquote><div><p>Diagnose: Azinäres Adenokarzinom der Prostata (ICD-O 8140/3) mit invasiven kribriformen Anteilen und intraduktaler Karzinomkomponente. Gleason-Score 4+5=9, ISUP-Gradgruppe 5 (WHO 2016). Prozentualer Anteil Gleasonmuster 4 und 5: 90%. Ausgedehnte Tumorinfiltration, ca. 60% des Prostatagewebes befallen. Extraprostatische Ausbreitung nachgewiesen. Samenblaseninfiltration nachgewiesen. Lymphovaskuläre Invasion nachgewiesen. Perineurale Infiltration nachgewiesen. Empfehlung: Staging-Untersuchungen und interdisziplinäre Tumorkonferenz.</p>
</div></blockquote>By Practitioner/PathologistPractitioner @2024-05-12</td><td>2024-05-12</td></tr></table><p>Prostata Enucleation: Azinäres Adenokarzinom, Gleason Score 4+5=9 (ISUP Grade Group 5), mit invasiven cribriformen Anteilen und intraduktalem Karzinom. Extensive Tumorinfiltration (60% des Gewebes) mit extraprostatischer Extension, Samenblaseninvasion, perineuralem und lymphovaskulärem Befall.</p></div>
        </text>
        <identifier>
          <type>
            <coding>
              <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
              <code value="ACSN"/>
              <display value="Accession ID"/>
            </coding>
          </type>
          <system value="https://pathologie.example-hospital.de/fhir/fn/befundbericht"/>
          <value value="E_24_004"/>
        </identifier>
        <basedOn>
          <reference value="ServiceRequest/TransurethralEnucleationReportRequest"/>
        </basedOn>
        <status value="final"/>
        <category>
          <coding>
            <system value="http://terminology.hl7.org/CodeSystem/v2-0074"/>
            <code value="SP"/>
            <display value="Surgical Pathology"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://loinc.org"/>
            <code value="60568-3"/>
            <display value="Pathology Synoptic report"/>
          </coding>
        </code>
        <subject>
          <reference value="Patient/Patient3"/>
        </subject>
        <effectiveDateTime value="2024-05-12T17:00:00+01:00"/>
        <issued value="2024-05-13T08:00:00+01:00"/>
        <performer>
          <reference value="Practitioner/PathologistPractitioner"/>
        </performer>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenPart"/>
        </specimen>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenBlock01"/>
        </specimen>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenSlide01A"/>
        </specimen>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenSlide01B"/>
        </specimen>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenBlock02"/>
        </specimen>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenSlide02A"/>
        </specimen>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenSlide02B"/>
        </specimen>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenBlock03"/>
        </specimen>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenSlide03A"/>
        </specimen>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenSlide03B"/>
        </specimen>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenBlock04"/>
        </specimen>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenSlide04A"/>
        </specimen>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenSlide04B"/>
        </specimen>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenBlock05"/>
        </specimen>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenSlide05A"/>
        </specimen>
        <specimen>
          <reference value="Specimen/TransurethralEnucleationSpecimenSlide05B"/>
        </specimen>
        <result>
          <reference value="Observation/TransurethralEnucleationMacroscopicGrouper"/>
        </result>
        <result>
          <reference value="Observation/TransurethralEnucleationDiagnosticConclusionGrouper"/>
        </result>
        <conclusion value="Prostata Enucleation: Azinäres Adenokarzinom, Gleason Score 4+5=9 (ISUP Grade Group 5), mit invasiven cribriformen Anteilen und intraduktalem Karzinom. Extensive Tumorinfiltration (60% des Gewebes) mit extraprostatischer Extension, Samenblaseninvasion, perineuralem und lymphovaskulärem Befall."/>
      </DiagnosticReport>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://prostatecancerspec.org/Observation/TransurethralEnucleationDiagnosticConclusionGrouper"/>
    <resource>
      <Observation>
        <id value="TransurethralEnucleationDiagnosticConclusionGrouper"/>
        <meta>
          <profile value="https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-diagnostic-conclusion-grouper|2026.0.0"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_TransurethralEnucleationDiagnosticConclusionGrouper"> </a><p class="res-header-id"><b>Generated Narrative: Observation TransurethralEnucleationDiagnosticConclusionGrouper</b></p><a name="TransurethralEnucleationDiagnosticConclusionGrouper"> </a><a name="hcTransurethralEnucleationDiagnosticConclusionGrouper"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="https://simplifier.net/resolve?scope=de.medizininformatikinitiative.kerndatensatz.patho@2026.0.0&amp;canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-diagnostic-conclusion-grouper">MII PR Patho Diagnostic Conclusion Grouperversion: null2026.0.0)</a></p></div><p><b>basedOn</b>: <a href="ServiceRequest-TransurethralEnucleationReportRequest.html">ServiceRequest Simple prostatectomy (procedure)</a></p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/observation-category laboratory}">Laboratory</span></p><p><b>code</b>: <span title="Codes:{http://loinc.org 22637-3}">Pathology report final diagnosis Narrative</span></p><p><b>subject</b>: <a href="Patient-Patient3.html">Klaus Becker  Male, DoB: 1958-11-10 ( http://example.hospital.de/patient-ids#PAT-2024-003)</a></p><p><b>effective</b>: 2024-05-12</p><p><b>performer</b>: <a href="Practitioner-PathologistPractitioner.html">Practitioner Maria Schneider </a></p><p><b>note</b>: By Practitioner/PathologistPractitioner @2024-05-12</p><blockquote><div><p>Diagnose: Azinäres Adenokarzinom der Prostata (ICD-O 8140/3) mit invasiven kribriformen Anteilen und intraduktaler Karzinomkomponente. Gleason-Score 4+5=9, ISUP-Gradgruppe 5 (WHO 2016). Prozentualer Anteil Gleasonmuster 4 und 5: 90%. Ausgedehnte Tumorinfiltration, ca. 60% des Prostatagewebes befallen. Extraprostatische Ausbreitung nachgewiesen. Samenblaseninfiltration nachgewiesen. Lymphovaskuläre Invasion nachgewiesen. Perineurale Infiltration nachgewiesen. Empfehlung: Staging-Untersuchungen und interdisziplinäre Tumorkonferenz.</p>
</div></blockquote><p><b>hasMember</b>: </p><ul><li><a href="Observation-TransurethralEnucleationHistologicalTypeICDO3.html">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href="Observation-TransurethralEnucleationMorphologyFreeText.html">Observation Histology type in Cancer specimen Narrative</a></li><li><a href="Observation-TransurethralEnucleationPrimaryGleasonPattern.html">Observation Gleason pattern.primary in Prostate tumor</a></li><li><a href="Observation-TransurethralEnucleationSecondaryGleasonPattern.html">Observation Gleason pattern.secondary in Prostate tumor</a></li><li><a href="Observation-TransurethralEnucleationGleasonScoreTotal.html">Observation Gleason score in Specimen Qualitative</a></li><li><a href="Observation-TransurethralEnucleationPercentageGleason45.html">Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area</a></li><li><a href="Observation-TransurethralEnucleationGradingGroupISUP.html">Observation Prostate cancer grade group [Score] in Prostate tumor Qualitative</a></li><li><a href="Observation-TransurethralEnucleationIntraductalCarcinoma.html">Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)</a></li><li><a href="Observation-TransurethralEnucleationInvasiveCribriformCarcinoma.html">Observation Invasive cribriform carcinoma (morphologic abnormality)</a></li><li><a href="Observation-TransurethralEnucleationProstaticTissueInvolved.html">Observation Tissue cores.positive.carcinoma in Tissue core</a></li><li><a href="Observation-TransurethralEnucleationExtraprostaticExtension.html">Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-TransurethralEnucleationSeminalVesicleInvasion.html">Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-TransurethralEnucleationLymphovascularInvasion.html">Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols</a></li><li><a href="Observation-TransurethralEnucleationPerineuralInfiltration.html">Observation Perineural invasion [Presence] in Cancer specimen</a></li></ul><p><b>derivedFrom</b>: <a href="QuestionnaireResponse-QuestionnaireResponseTransurethralEnucleation.html">Response to Questionnaire 'https://art-decor.org/fhir/Questionnaire/2.16.840.1.113883.3.1937.777.18.27.20--20250115134435' about '-&gt;Klaus Becker  Male, DoB: 1958-11-10 ( http://example.hospital.de/patient-ids#PAT-2024-003)'</a></p></div>
        </text>
        <basedOn>
          <reference value="ServiceRequest/TransurethralEnucleationReportRequest"/>
        </basedOn>
        <status value="final"/>
        <category>
          <coding>
            <system value="http://terminology.hl7.org/CodeSystem/observation-category"/>
            <code value="laboratory"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://loinc.org"/>
            <code value="22637-3"/>
          </coding>
        </code>
        <subject>
          <reference value="Patient/Patient3"/>
        </subject>
        <effectiveDateTime value="2024-05-12"/>
        <performer>
          <reference value="Practitioner/PathologistPractitioner"/>
        </performer>
        <note>
          <authorReference>
            <reference value="Practitioner/PathologistPractitioner"/>
          </authorReference>
          <time value="2024-05-12"/>
          <text value="Diagnose: Azinäres Adenokarzinom der Prostata (ICD-O 8140/3) mit invasiven kribriformen Anteilen und intraduktaler Karzinomkomponente. Gleason-Score 4+5=9, ISUP-Gradgruppe 5 (WHO 2016). Prozentualer Anteil Gleasonmuster 4 und 5: 90%. Ausgedehnte Tumorinfiltration, ca. 60% des Prostatagewebes befallen. Extraprostatische Ausbreitung nachgewiesen. Samenblaseninfiltration nachgewiesen. Lymphovaskuläre Invasion nachgewiesen. Perineurale Infiltration nachgewiesen. Empfehlung: Staging-Untersuchungen und interdisziplinäre Tumorkonferenz."/>
        </note>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationHistologicalTypeICDO3"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationMorphologyFreeText"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationPrimaryGleasonPattern"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationSecondaryGleasonPattern"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationGleasonScoreTotal"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationPercentageGleason45"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationGradingGroupISUP"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationIntraductalCarcinoma"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationInvasiveCribriformCarcinoma"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationProstaticTissueInvolved"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationExtraprostaticExtension"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationSeminalVesicleInvasion"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationLymphovascularInvasion"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationPerineuralInfiltration"/>
        </hasMember>
        <derivedFrom>
          <reference value="QuestionnaireResponse/QuestionnaireResponseTransurethralEnucleation"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl value="http://prostatecancerspec.org/Observation/TransurethralEnucleationMacroscopicGrouper"/>
    <resource>
      <Observation>
        <id value="TransurethralEnucleationMacroscopicGrouper"/>
        <meta>
          <profile value="https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-macroscopic-grouper|2026.0.0"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_TransurethralEnucleationMacroscopicGrouper"> </a><p class="res-header-id"><b>Generated Narrative: Observation TransurethralEnucleationMacroscopicGrouper</b></p><a name="TransurethralEnucleationMacroscopicGrouper"> </a><a name="hcTransurethralEnucleationMacroscopicGrouper"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="https://simplifier.net/resolve?scope=de.medizininformatikinitiative.kerndatensatz.patho@2026.0.0&amp;canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-macroscopic-grouper">MII PR Patho Macroscopic Grouperversion: null2026.0.0)</a></p></div><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/observation-category laboratory}">Laboratory</span></p><p><b>code</b>: <span title="Codes:{http://loinc.org 22634-0}">Pathology report gross observation Narrative</span></p><p><b>subject</b>: <a href="Patient-Patient3.html">Klaus Becker  Male, DoB: 1958-11-10 ( http://example.hospital.de/patient-ids#PAT-2024-003)</a></p><p><b>effective</b>: 2024-04-11 14:00:00+0100</p><p><b>performer</b>: <a href="Practitioner-PathologistPractitioner.html">Practitioner Maria Schneider </a></p><p><b>value</b>: Makroskopische Messungen des Prostata Enucleation Präparats</p><p><b>note</b>: </p><blockquote><div><p>Makroskopische Aufarbeitung des Prostata Enucleation Präparats: Gewicht 25g, Länge 3.5cm, Breite 2.8cm, Tiefe 2.2cm. Keine Samenblasen im Resektat. Keine Lymphknoten im Resektat.</p>
</div></blockquote><p><b>bodySite</b>: <span title="Codes:{http://snomed.info/sct 41216001}">Prostatic structure (body structure)</span></p><p><b>hasMember</b>: </p><ul><li><a href="Observation-TransurethralEnucleationMacroscopicWeight.html">Observation Specimen weight (observable entity)</a></li><li><a href="Observation-TransurethralEnucleationMacroscopicLength.html">Observation Dimension [Length] of Specimen</a></li><li><a href="Observation-TransurethralEnucleationMacroscopicWidth.html">Observation Dimension [Length] of Specimen</a></li><li><a href="Observation-TransurethralEnucleationMacroscopicDepth.html">Observation Prostate size</a></li><li><a href="Observation-TransurethralEnucleationMacroscopicSeminalVesicles.html">Observation Tumor finding</a></li><li><a href="Observation-TransurethralEnucleationMacroscopicLymphNodeDissection.html">Observation Tumor finding</a></li></ul><p><b>derivedFrom</b>: <a href="QuestionnaireResponse-QuestionnaireResponseTransurethralEnucleation.html">Response to Questionnaire 'https://art-decor.org/fhir/Questionnaire/2.16.840.1.113883.3.1937.777.18.27.20--20250115134435' about '-&gt;Klaus Becker  Male, DoB: 1958-11-10 ( http://example.hospital.de/patient-ids#PAT-2024-003)'</a></p></div>
        </text>
        <status value="final"/>
        <category>
          <coding>
            <system value="http://terminology.hl7.org/CodeSystem/observation-category"/>
            <code value="laboratory"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://loinc.org"/>
            <code value="22634-0"/>
          </coding>
        </code>
        <subject>
          <reference value="Patient/Patient3"/>
        </subject>
        <effectiveDateTime value="2024-04-11T14:00:00+01:00"/>
        <performer>
          <reference value="Practitioner/PathologistPractitioner"/>
        </performer>
        <valueString value="Makroskopische Messungen des Prostata Enucleation Präparats"/>
        <note>
          <text value="Makroskopische Aufarbeitung des Prostata Enucleation Präparats: Gewicht 25g, Länge 3.5cm, Breite 2.8cm, Tiefe 2.2cm. Keine Samenblasen im Resektat. Keine Lymphknoten im Resektat."/>
        </note>
        <bodySite>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="41216001"/>
            <display value="Prostatic structure (body structure)"/>
          </coding>
        </bodySite>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationMacroscopicWeight"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationMacroscopicLength"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationMacroscopicWidth"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationMacroscopicDepth"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationMacroscopicSeminalVesicles"/>
        </hasMember>
        <hasMember>
          <reference value="Observation/TransurethralEnucleationMacroscopicLymphNodeDissection"/>
        </hasMember>
        <derivedFrom>
          <reference value="QuestionnaireResponse/QuestionnaireResponseTransurethralEnucleation"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
</Bundle>